- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06232850
Wrist Position Sense in Individuals With Multiple Sclerosis
Examining the Relationship Between Wrist Position Sense and Manual Dexterity in Individuals With Multiple Sclerosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Multiple sclerosis is a chronic demyelinating disease of the central nervous system that occurs in young adults and usually progresses with attacks and remissions. As the disease progresses, symptoms such as fatigue, muscle weakness, loss of balance, loss of sensation, spasticity, visual disturbances and bladder dysfunction are observed. In addition to these symptoms, hand functions may be affected even in the early stages of the disease.
Appropriate motor control and mobility skills are required to perform manual dexterity effectively. Joint stabilization and perception of the joint's position and movement in space are needed for motor control of hand functions. In this process, position sense signals contribute significantly to the target localization and performance of the hand. Position sense signals must be constantly updated for the coordination and integration of hand position during manual activities such as holding or grasping an object. This is possible with a healthy sense of position.
Although it is known that position sense is affected in MS patients, no study has been found examining the effect of wrist position sense on manual dexterity. The purpose of this study is to examine the effect of wrist position sense on hand dexterity. Patients' manual dexterity will be evaluated using the Purdue Pegboard Test, and wrist position sense will be evaluated using the K-FORCE Sens® electrogoniometer.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Deni̇zli̇
-
Denizli, Deni̇zli̇, Turkey, 20160
- Müge içelli güneş
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient group:
- Disability score (EDSS: Expanded Disability Status Scale) should be between 0-3.
- Being between the ages of 18-50
- Not having had an attack in the last 3 months
- Scoring 24 points or above on the Mini-Mental State Examination
- Patients diagnosed with relapsing-remitting MS with a disease duration of at least 2 years
- Patients without spasticity according to MAS
Control group:
- Volunteers in a similar age range who agreed to participate in the study
- Being between the ages of 18-50
Exclusion Criteria:
Patient group:
- Presence of diagnosed visual impairment
- Having other chronic diseases not related to MS
- Having any orthopedic, neurological, rheumatological or metabolic diagnosis that causes upper extremity involvement
- History of hand and upper extremity disorders, peripheral nerve disorders, and medical or psychiatric disorders that may significantly affect cognitive function
- Presence of wrist joint range of motion limitation
Control group:
- Having any orthopedic, neurological, rheumatological or metabolic diagnosis that causes upper extremity involvement
- History of hand and upper extremity disorders, peripheral nerve disorders, and medical or psychiatric disorders that may significantly affect cognitive function
- Presence of wrist joint range of motion limitation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Multiple sclerosis patient
According to EDSS should be between 0-3, not having had an attack in the last 3 months and without spasticity according to MAS in patient with MS will assesment KFORCE Sens® device and Purdue Pegboard Test.
|
Position sense and manual dexterity evaluate
|
Healthy group
Healthy people of similar age who agree to participate in the study will evaluate the KFORCE Sens® device and the Purdue Pegboard Test.
|
Position sense and manual dexterity evaluate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wrist Position Sense Assessment
Time Frame: four mounth
|
Wrist position sense will be assessed with the KFORCE Sens® electrogoniometer.
Target measurement values of 30° for wrist flexion, 30° for extension, 10° for radial deviation and 15° for ulnar deviation will be used.
|
four mounth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Purdue Pegboard Test (PPT)
Time Frame: four mounth
|
PPT evaluates the gross motor skills of the arm, hand and fingers, as well as the fine motor skills of the fingers and fingertips, both unilaterally and bilaterally.
It consists of pins, washers, nuts and assembly tests.
The test consists of 5 sub-steps (inserting pins with the dominant/non-dominant hand/both hands, mathematical summation and assembly).
The scoring of the test is the total number of pins, washers and nuts installed at the end of the given period.
One trial will be made for each subtest.
|
four mounth
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Müge İçelli Güneş, M.Sc., Pamukkale University Denizli Health Services Vocational School of Higher Education
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PU-FTR-MI-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Position sense and manual dexterity evaluate
-
University of PortsmouthSolent NHS Trust; The Sir Halley Stewart TrustCompleted
-
Cairo UniversityCompletedCOVID-19 PneumoniaEgypt
-
Hacettepe UniversityNot yet recruitingQuality of Life | Amputation | Balance | Muscle Activation | Sense of ControlTurkey
-
Womack Army Medical CenterUnited States Naval Medical Center, San Diego; C.R.Darnall Army Medical CenterNot yet recruitingMyopericarditis | Small Pox
-
Bahçeşehir UniversityCompletedInjury;SportsTurkey
-
Anne-Violette BruynnelUniversity Hospital, GenevaCompleted
-
Cairo UniversityCompletedIron Deficiency AnemiaEgypt